37Z-20502-25371

4 vaccinations 11 coded responses 32 check-ins 10 free-text entries 3 call cases

Sex: Female
Age at first dose: 66+
ZIP prefix: 894 / NV
Registered: 2021-04-05

Relationship: Self
Race: White
Ethnicity: Not Hispanic or Latino

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-03-08
Dose 1 — Moderna
2021-04-05
Registered in v-safe
2021-04-05
Dose 2 — Moderna
2021-04-05
Survey response — day 0, dose 2
MedDRA: Paraesthesia oral — Feeling: Fair · Site: Swelling · Fatigue or tiredness

Free text: Tingling tongue

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-04-06
Survey response — days 1–6 daily, dose 2
MedDRA: Paraesthesia oral — Feeling: Poor · Site: Pain, Swelling · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities

Free text: Tongue tingles

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-04-07
Health check-in — days 1–6 daily, dose 2
Feeling: Poor · Site: Pain · Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities

Adult check-in
2021-04-08
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Site: Itching · Headache, Joint pains, Fatigue or tiredness

Adult check-in
2021-04-09
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Site: Itching · Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities

Adult check-in
2021-04-10
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Joint pains, Fatigue or tiredness

Adult check-in
2021-04-11
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Site: Itching · None

Adult check-in
2021-04-12
Health check-in — day 7, dose 2
Feeling: Good · Fatigue or tiredness

Adult check-in
2021-04-19
Health check-in — day 14, dose 2
Feeling: Good

Adult check-in
2021-04-26
Health check-in — day 21, dose 2
Feeling: Good

Adult check-in
2021-05-03
Survey response — day 28, dose 2
MedDRA: Arthritis, Pre-existing disease — Feeling: Good · Be unable to do your normal daily activities

Free text: Arthritis flare

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-05-10
Health check-in — day 35, dose 2
Feeling: Good

Adult check-in
2021-05-17
Survey response — day 42, dose 2
MedDRA: Arthralgia, Arthritis, Headache, Office visit, Pre-existing disease — Feeling: Fair · Get care from a doctor or other healthcare professional

Free text: Symptoms: Arthritis flare and joint pain with headaches. · Healthcare visit (other): Scheduled with rheumatologist

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-05-17
Report sent to call center — day 42, dose 2
Get care from a doctor or other healthcare professional

1 call case(s)
2021-07-05
Health check-in — 3 months, dose 2
Feeling: Good

Adult check-in
2021-10-04
Survey response — 6 months, dose 2
MedDRA: Fatigue, Headache, Lymphoedema, Musculoskeletal stiffness, Osteoarthritis, Pain in extremity, Pre-existing disease, Somnolence — Feeling: Fair · Be unable to do your normal daily activities

Free text: Flares of osteoarthritis, headaches, lymphedema, painful hands and stiffness, extreme fatigue, falling asleep during the day.

MedDRA releases: 2024-11 · check-in free text available
2021-10-17
Dose 3 — Moderna
2021-10-26
Health check-in — day 7, dose 3
Feeling: Fair · Site: Pain, Itching · Fatigue or tiredness

Adult check-in
2021-10-31
Health check-in — day 14, dose 3
Feeling: Good

Adult check-in
2021-11-07
Health check-in — day 21, dose 3
Feeling: Good

Adult check-in
2021-11-14
Health check-in — day 28, dose 3
Feeling: Good

Adult check-in
2021-11-21
Health check-in — day 35, dose 3
Feeling: Good

Adult check-in
2021-11-28
Health check-in — day 42, dose 3
Feeling: Good

Adult check-in
2022-01-16
Survey response — 3 months, dose 3
MedDRA: Arthralgia, Cough, Eye pain, Fatigue, Headache, Medical counselling, Oropharyngeal pain, Pain, Pyrexia, SARS-CoV-2 test — Feeling: Poor · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional

Free text: Symptoms: Fever, body aches, headache headache, eyes hurt, cough and sore throat, joints ache and extreme fatigue · Healthcare visit (other): (b)(6) County Health Department came to my home to test me for Covid-19

MedDRA releases: 2024-11 · check-in free text available
2022-01-16
Report sent to call center — 3 months, dose 3
Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional

1 call case(s)
2022-01-18
Call 1 — Could Not Reach Participant
2022-01-21
Call successful
Does not wish to fill out VAERS report
2022-04-09
Dose 4 — Moderna
2022-04-14
Survey response — days 1–6 daily, dose 4
MedDRA: Vision blurred — Feeling: Fair · Site: Redness, Swelling, Itching · Muscle or body aches, Fatigue or tiredness

Free text: Blurry eyes

MedDRA releases: 2024-11 · check-in free text available
2022-04-16
Health check-in — day 7, dose 4
Feeling: Fair · Joint pains, Fatigue or tiredness · Be unable to do your normal daily activities

Adult check-in
2022-04-23
Health check-in — day 14, dose 4
Feeling: Fair

Adult check-in
2022-04-30
Health check-in — day 21, dose 4
Feeling: Good

Adult check-in
2022-05-07
Survey response — day 28, dose 4
MedDRA: Fatigue, Fluid retention, Somnolence — Feeling: Good · Be unable to do your normal daily activities

Free text: Fluid retention and extreme sleepiness and fatigue

MedDRA releases: 2024-11 · check-in free text available
2022-05-14
Survey response — day 35, dose 4
MedDRA: Fluid retention, Lymphoedema — Feeling: Fair · Be unable to do your normal daily activities

Free text: Fluid retention and lymphedema.

MedDRA releases: 2024-11 · check-in free text available
2022-05-21
Health check-in — day 42, dose 4
Feeling: Good

Adult check-in
2022-07-09
Health check-in — 3 months, dose 4
Feeling: Good

Adult check-in
2022-10-08
Survey response — 6 months, dose 4
MedDRA: Asthenia, Condition aggravated, Cough, Dysgeusia, Headache, Myalgia, Parosmia, Pre-existing disease, Vision blurred — Feeling: Fair · Be unable to do your normal daily activities

Free text: The classic headache, inflammatory flares, foul tastes and smells, weak and muscle aches. No fever. Blurring of sight intermittently and pesty bronchial cough.

MedDRA releases: 2024-11 · check-in free text available
2023-04-09
Survey response — 12 months, dose 4
MedDRA: Fatigue, Headache, Increased upper airway secretion, Office visit, Parosmia, Physiotherapy, Pre-existing disease, Rash, Taste disorder — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional

MedDRA releases: 2024-11
2023-04-09
Report sent to call center — 12 months, dose 4
Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional

1 call case(s)
2023-04-12
Call successful
Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-03-08	Moderna
2	2021-04-05	Moderna
3	2021-10-17	Moderna	No
4	2022-04-09	Moderna	No

Call center

3 call center cases

3 successful

See the call center timeline

Free text

Release 6 — day 0, dose 2

2021-04-05

Systemic reaction (other): Tingling tongue

Release 7 — days 1–6 daily, dose 2

2021-04-06

Systemic reaction (other): Tongue tingles

Release 8 — day 28, dose 2

2021-05-03

Symptoms: Arthritis flare

Release 8 — day 42, dose 2

2021-05-17

Symptoms: Arthritis flare and joint pain with headaches.

Healthcare visit (other): Scheduled with rheumatologist

Release 10 — 6 months, dose 2

2021-10-04

Symptoms: Flares of osteoarthritis, headaches, lymphedema, painful hands and stiffness, extreme fatigue, falling asleep during the day.

Release 10 — 3 months, dose 3

2022-01-16

Symptoms: Fever, body aches, headache headache, eyes hurt, cough and sore throat, joints ache and extreme fatigue

Healthcare visit (other): (b)(6) County Health Department came to my home to test me for Covid-19

redacted (b)(6)

Release 11 — days 1–6 daily, dose 4

2022-04-14

Systemic reaction (other): Blurry eyes

Release 11 — day 28, dose 4

2022-05-07

Symptoms: Fluid retention and extreme sleepiness and fatigue

Release 11 — day 35, dose 4

2022-05-14

Symptoms: Fluid retention and lymphedema.

Release 12 — 6 months, dose 4

2022-10-08

Symptoms: The classic headache, inflammatory flares, foul tastes and smells, weak and muscle aches. No fever. Blurring of sight intermittently and pesty bronchial cough.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
HCVO	Medical counselling	·	·	✓
HCVO	Office visit	✓	✓	✓
HCVO	Physiotherapy	·	·	✓
HCVO	SARS-CoV-2 test	·	·	✓
SD	Arthralgia	✓	✓	✓
SD	Arthritis	✓	✓	✓
SD	Asthenia	·	·	✓
SD	Condition aggravated	·	·	✓
SD	Cough	·	·	✓
SD	Dysgeusia	·	·	✓
SD	Eye pain	·	·	✓
SD	Fatigue	·	·	✓
SD	Fluid retention	·	·	✓
SD	Headache	✓	✓	✓
SD	Increased upper airway secretion	·	·	✓
SD	Lymphoedema	·	·	✓
SD	Musculoskeletal stiffness	·	·	✓
SD	Myalgia	·	·	✓
SD	Oropharyngeal pain	·	·	✓
SD	Osteoarthritis	·	·	✓
SD	Pain	·	·	✓
SD	Pain in extremity	·	·	✓
SD	Parosmia	·	·	✓
SD	Pre-existing disease	✓	✓	✓
SD	Pyrexia	·	·	✓
SD	Rash	·	·	✓
SD	Somnolence	·	·	✓
SD	Taste disorder	·	·	✓
SD	Vision blurred	·	·	✓
SRO	Paraesthesia oral	✓	✓	✓
SRO	Vision blurred	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release